Di Mascolo, D.; Varesano, S.; Benelli, R.; Mollica, H.; Salis, A.; Zocchi, M.R.; Decuzzi, P.; Poggi, A.
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer. Cancers 2020, 12, 104.
https://doi.org/10.3390/cancers12010104
AMA Style
Di Mascolo D, Varesano S, Benelli R, Mollica H, Salis A, Zocchi MR, Decuzzi P, Poggi A.
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer. Cancers. 2020; 12(1):104.
https://doi.org/10.3390/cancers12010104
Chicago/Turabian Style
Di Mascolo, Daniele, Serena Varesano, Roberto Benelli, Hilaria Mollica, Annalisa Salis, Maria Raffaella Zocchi, Paolo Decuzzi, and Alessandro Poggi.
2020. "Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer" Cancers 12, no. 1: 104.
https://doi.org/10.3390/cancers12010104
APA Style
Di Mascolo, D., Varesano, S., Benelli, R., Mollica, H., Salis, A., Zocchi, M. R., Decuzzi, P., & Poggi, A.
(2020). Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer. Cancers, 12(1), 104.
https://doi.org/10.3390/cancers12010104